Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Obesity × Propofol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Neoplasms 14 Lung Neoplasms 10 Colonic Neoplasms 9 Breast Neoplasms 9 Brain Neoplasms 7 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pituitary Neoplasms 3 Neoplastic Cells, Circulating 3 Emergence Delirium 3 Carcinoma, Hepatocellular 3 Agnosia 3 Respiratory Aspiration 2 Postoperative Complications 2 Pain, Postoperative 2 Ovarian Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Hypoxia 2 Delirium 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Abdominal Neoplasms 2 Uterine Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Nodule 1 Thoracic Diseases 1 Supratentorial Neoplasms 1

Interventions

Exercise 22 Metformin 14 Tirzepatide 8 Diet 8 Resistance Training 7 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 6 semaglutide 5 Exenatide 5 Early Intervention, Educational 5 Diet, Mediterranean 5 Caloric Restriction 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Bariatric Surgery 4 Vitamin D 3 Standard of Care 3 Naltrexone 3 Letrozole 3 Docosahexaenoic Acids 3 Dexamethasone 3 Bupropion 3 exemestane 2 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2 Topiramate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05518929 2024-06-07

SpO2

RenJi Hospital

Phase 4 Completed

GastrointestinalOther

Obesity, Stomach Neoplasms, Stomach Ulcer, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡